What is the point of IVIVCs for generics? [Dissolution / BCS / IVIVC]

posted by CLR – Singapore, 2016-04-11 12:12 (2909 d 00:31 ago) – Posting: # 16181
Views: 10,568

Hi everyone,

I was recently involved in some discussions about BE training and the topic of IVIVCs came up. I also came across a publication from last year by a bunch of USFDA reviewers about applying IVIVCs in generic drug development. Based on my rather limited experience, despite the benefits that an IVIVC brings, many generic companies either don't do them for their oral extended-release products or don't do them correctly. As many of you have direct working experience either with or within generic drug companies, could you perhaps share why you think this is the case? If it's such an uphill climb, is there any point in trying to sell IVIVCs to the generic drug companies?

Looking forward to hearing your views :-D

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
83 visitors (0 registered, 83 guests [including 6 identified bots]).
Forum time: 11:44 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5